Symmetric dimethylarginine (SDMA) is a new kidney function test that helps detect kidney disease earlier and identifies progression of chronic kidney disease (CKD) as dogs and cats lose weight. Two clinical cases illustrate the use of updated IRIS CKD staging and treatment guidelines and highlight the value of SDMA. In these two cases, investigating an increased SDMA led to treatment of kidney disease and practical management decisions that improved patient health.